Nicholas Hollmeyer Lynton
CIK: 0001941467
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Cardlytics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (45 total)
- Jul 2, 2026CDLX
Cardlytics, Inc.
Sale(S)Direct2.2K shares at avg. $4.39$9K - Jul 1, 2026CDLX
Cardlytics, Inc.
Exercise(M)Direct2.8K shares- - Jul 1, 2026CDLX
Cardlytics, Inc.
Exercise(M)Direct312 shares- - Jul 1, 2026CDLX
Cardlytics, Inc.
Exercise(M)Direct157 shares- - Jul 1, 2026CDLX
Cardlytics, Inc.
Exercise(M)Direct1.5K shares- - Apr 1, 2026CDLX
Cardlytics, Inc.
Exercise(M)Direct10.6K shares- - Apr 1, 2026CDLX
Cardlytics, Inc.
Exercise(M)Direct582 shares- - Apr 1, 2026CDLX
Cardlytics, Inc.
Exercise(M)Direct1.6K shares- - Apr 1, 2026CDLX
Cardlytics, Inc.
Sale(S)Direct40.3K shares at avg. $0.99$40K - Apr 1, 2026CDLX
Cardlytics, Inc.
Exercise(M)Direct60K shares- - Apr 1, 2026CDLX
Cardlytics, Inc.
Exercise(M)Direct12.5K shares- - Feb 18, 2026CDLX
Cardlytics, Inc.
Award(A)DirectRestricted Stock Unit
220K shares- - Jan 5, 2026CDLX
Cardlytics, Inc.
Sale(S)Direct6.3K shares at avg. $1.17$7K - Jan 1, 2026CDLX
Cardlytics, Inc.
Exercise(M)Direct581 shares- - Jan 1, 2026CDLX
Cardlytics, Inc.
Exercise(M)Direct1.6K shares- - Jan 1, 2026CDLX
Cardlytics, Inc.
Exercise(M)Direct10.6K shares- - Oct 2, 2025CDLX
Cardlytics, Inc.
Sale(S)Direct6.1K shares at avg. $2.27$14K - Oct 1, 2025CDLX
Cardlytics, Inc.
Exercise(M)Direct10.6K shares- - Oct 1, 2025CDLX
Cardlytics, Inc.
Exercise(M)Direct581 shares- - Oct 1, 2025CDLX
Cardlytics, Inc.
Exercise(M)Direct1.6K shares- - Jul 2, 2025CDLX
Cardlytics, Inc.
Sale(S)Direct5.3K shares at avg. $1.78$9K - Jul 1, 2025CDLX
Cardlytics, Inc.
Exercise(M)Direct581 shares- - Jul 1, 2025CDLX
Cardlytics, Inc.
Exercise(M)Direct10.6K shares- - Jul 1, 2025CDLX
Cardlytics, Inc.
Exercise(M)Direct1.6K shares- - Jun 23, 2025CDLX
Cardlytics, Inc.
Award(A)DirectRestricted Stock Units
25K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 2, 2026 | CDLX Cardlytics, Inc. | Sale(S) | 2,151 | $4.39 | $9,454 | Direct |
| Jul 1, 2026 | CDLX Cardlytics, Inc. | Exercise(M) | 2,750 | - | $0 | Direct |
| Jul 1, 2026 | CDLX Cardlytics, Inc. | Exercise(M) | 312 | - | $0 | Direct |
| Jul 1, 2026 | CDLX Cardlytics, Inc. | Exercise(M) | 157 | - | $0 | Direct |
| Jul 1, 2026 | CDLX Cardlytics, Inc. | Exercise(M) | 1,500 | - | $0 | Direct |
| Apr 1, 2026 | CDLX Cardlytics, Inc. | Exercise(M) | 10,630 | - | $0 | Direct |
| Apr 1, 2026 | CDLX Cardlytics, Inc. | Exercise(M) | 582 | - | $0 | Direct |
| Apr 1, 2026 | CDLX Cardlytics, Inc. | Exercise(M) | 1,578 | - | $0 | Direct |
| Apr 1, 2026 | CDLX Cardlytics, Inc. | Sale(S) | 40,296 | $0.99 | $39,893 | Direct |
| Apr 1, 2026 | CDLX Cardlytics, Inc. | Exercise(M) | 60,000 | - | $0 | Direct |
| Apr 1, 2026 | CDLX Cardlytics, Inc. | Exercise(M) | 12,500 | - | $0 | Direct |
| Feb 18, 2026 | CDLX Cardlytics, Inc. | Award(A) Restricted Stock Unit | 220,000 | - | - | Direct |
| Jan 5, 2026 | CDLX Cardlytics, Inc. | Sale(S) | 6,253 | $1.17 | $7,316 | Direct |
| Jan 1, 2026 | CDLX Cardlytics, Inc. | Exercise(M) | 581 | - | $0 | Direct |
| Jan 1, 2026 | CDLX Cardlytics, Inc. | Exercise(M) | 1,578 | - | $0 | Direct |
| Jan 1, 2026 | CDLX Cardlytics, Inc. | Exercise(M) | 10,629 | - | $0 | Direct |
| Oct 2, 2025 | CDLX Cardlytics, Inc. | Sale(S) | 6,098 | $2.27 | $13,849 | Direct |
| Oct 1, 2025 | CDLX Cardlytics, Inc. | Exercise(M) | 10,630 | - | - | Direct |
| Oct 1, 2025 | CDLX Cardlytics, Inc. | Exercise(M) | 581 | - | - | Direct |
| Oct 1, 2025 | CDLX Cardlytics, Inc. | Exercise(M) | 1,578 | - | - | Direct |
| Jul 2, 2025 | CDLX Cardlytics, Inc. | Sale(S) | 5,271 | $1.78 | $9,396 | Direct |
| Jul 1, 2025 | CDLX Cardlytics, Inc. | Exercise(M) | 581 | - | - | Direct |
| Jul 1, 2025 | CDLX Cardlytics, Inc. | Exercise(M) | 10,629 | - | - | Direct |
| Jul 1, 2025 | CDLX Cardlytics, Inc. | Exercise(M) | 1,578 | - | - | Direct |
| Jun 23, 2025 | CDLX Cardlytics, Inc. | Award(A) Restricted Stock Units | 25,000 | - | - | Direct |
1-25 of 45 transactions
About Lynton Nicholas Hollmeyer
Lynton Nicholas Hollmeyer (SEC CIK 0001941467) files insider reports with the SEC as Chief Legal & Privacy Officer of Cardlytics, Inc. (CDLX).
Signal8 holds 13 ownership filings by Lynton Nicholas Hollmeyer, all Form 4s, filed between Oct 3, 2024 and Jul 6, 2026. Those filings report 45 transactions, from Oct 1, 2024 to Jul 2, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Lynton Nicholas Hollmeyer's filings is in ATLANTA, GA.
Recent filings by Lynton Nicholas Hollmeyer
- Jul 2, 2026: Open-market sale of CDLX shares (Form 4, code S).
- Jul 1, 2026: Option exercises of CDLX shares (4 lines, Form 4, code M).
- Apr 1, 2026: Option exercises of CDLX shares (3 lines, Form 4, code M).
- Apr 1, 2026: Open-market sale of CDLX shares (Form 4, code S).
- Apr 1, 2026: Option exercises of CDLX shares (2 lines, Form 4, code M).
Other insiders filing for Cardlytics, Inc. (CDLX)
- Gupta Amit, Chief Executive Officer
- Hornsey Liane, Director
- Gupta Srishti A., Director
- Francis Jonathan Edward, Director
- Fernandez Andre J, Director
- Klinck John L. Jr., Director